The US Food and Drug Administration has issued final guidance to help manufacturers develop and conduct studies for in vitro diagnostic devices to support their pre-market submissions1,2.
The guidance contains recommendations for studies to support pre-market notification and approval of IVDs and does not address the use of investigational devices in clinical studies designed to evaluate new drug products...
Please login to read the full article.
